See All Slides - tctmd.com

Slides

Presentation TCT 2016

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson

November 01, 2016

Presentation TCT 2016

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson

November 01, 2016

Presentation TCT 2016

Hypogastric Embolization Is No Longer Necessary in Aorto-iliac EVAR With Contemporary Devices and Techniques

Presenter: D. Christopher Metzger, Peter A. Schneider, Brian G. DeRubertis

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Presenter: Ted Feldman, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Subgroup Analyses: How Useful or Harmful Are They?

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Sanjay Kaul

November 01, 2016

Presentation TCT 2016

Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR

Presenter: D. Christopher Metzger, Peter A. Schneider, Barry T. Katzen

November 01, 2016

Presentation TCT 2016

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert

November 01, 2016

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

Presentation TCT 2016

Low-Profile Devices Have Expanded Treatment Options for Patients Undergoing EVAR

Presenter: D. Christopher Metzger, Peter A. Schneider, Ehrin J. Armstrong

November 01, 2016

Advertisement

Slides

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Hypogastric Embolization Is No Longer Necessary in Aorto-iliac EVAR With Contemporary Devices and Techniques

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Subgroup Analyses: How Useful or Harmful Are They?

Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Low-Profile Devices Have Expanded Treatment Options for Patients Undergoing EVAR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content